Indo Us Bio-Tech Limited (NSE:INDOUS)
91.21
+1.55 (1.73%)
Jun 19, 2026, 3:30 PM IST
Indo Us Bio-Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 61.23 | 2.48 | 10.98 | 1.9 | 0.49 |
Cash & Short-Term Investments | 61.23 | 2.48 | 10.98 | 1.9 | 0.49 |
Cash Growth | 2370.50% | -77.44% | 479.59% | 285.03% | -63.38% |
Accounts Receivable | 137.59 | 150.01 | 190.45 | 247.42 | 205.47 |
Other Receivables | - | 0.01 | 0.01 | 0.9 | - |
Receivables | 137.59 | 150.02 | 190.46 | 248.32 | 205.47 |
Inventory | 999.54 | 706.86 | 517.35 | 269.13 | 233.57 |
Prepaid Expenses | - | 0.37 | 0.34 | 0.16 | 0.47 |
Other Current Assets | 8.57 | 7.53 | 11.77 | 79.58 | 28.38 |
Total Current Assets | 1,207 | 867.27 | 730.91 | 599.09 | 468.38 |
Property, Plant & Equipment | 117.19 | 102.34 | 104.7 | 87.35 | 78.77 |
Long-Term Deferred Tax Assets | 4.8 | 6.96 | 6.59 | 5.85 | 4.2 |
Other Long-Term Assets | 0.22 | 1.86 | 2.36 | 2.36 | 4.82 |
Total Assets | 1,331 | 978.43 | 844.56 | 694.65 | 556.16 |
Accounts Payable | 4.48 | 11.62 | 43.88 | 13.96 | 21.57 |
Accrued Expenses | 0.33 | 3.46 | 2.57 | 2 | 2.58 |
Short-Term Debt | - | 103.74 | 103.84 | 83.74 | 68.23 |
Current Portion of Long-Term Debt | 360.84 | 15.28 | 11.39 | 15.21 | 22.83 |
Current Income Taxes Payable | 4.43 | 3 | 3.52 | 0.97 | 0.97 |
Other Current Liabilities | 25.15 | 26.29 | 23.43 | 7.05 | 6.66 |
Total Current Liabilities | 395.23 | 163.39 | 188.63 | 122.93 | 122.84 |
Long-Term Debt | 9.52 | 29.34 | 28.02 | 17.05 | 37.33 |
Pension & Post-Retirement Benefits | 0.88 | 0.51 | 0.44 | 0.43 | 0.36 |
Other Long-Term Liabilities | - | - | -0 | 9.29 | 10.55 |
Total Liabilities | 405.63 | 193.24 | 217.09 | 149.69 | 171.09 |
Common Stock | 200.52 | 200.52 | 200.52 | 100.26 | 91.67 |
Additional Paid-In Capital | - | 221.19 | 221.19 | 221.19 | 146.02 |
Retained Earnings | - | 363.24 | 205.57 | 223.5 | 147.38 |
Comprehensive Income & Other | 724.82 | 0.24 | 0.18 | - | - |
Total Common Equity | 925.34 | 785.18 | 627.47 | 544.96 | 385.07 |
Minority Interest | - | - | - | - | 0.01 |
Shareholders' Equity | 925.34 | 785.18 | 627.47 | 544.96 | 385.08 |
Total Liabilities & Equity | 1,331 | 978.43 | 844.56 | 694.65 | 556.16 |
Total Debt | 370.36 | 148.36 | 143.24 | 115.99 | 128.39 |
Net Cash (Debt) | -309.13 | -145.88 | -132.26 | -114.1 | -127.9 |
Net Cash Per Share | -15.41 | -7.28 | -6.60 | -5.92 | -10.45 |
Filing Date Shares Outstanding | 20.12 | 20.05 | 20.05 | 20.05 | 18.33 |
Total Common Shares Outstanding | 20.12 | 20.05 | 20.05 | 20.05 | 18.33 |
Working Capital | 811.69 | 703.88 | 542.29 | 476.16 | 345.54 |
Book Value Per Share | 45.99 | 39.16 | 31.29 | 27.18 | 21.00 |
Tangible Book Value | 925.34 | 785.18 | 627.47 | 544.96 | 385.07 |
Tangible Book Value Per Share | 45.99 | 39.16 | 31.29 | 27.18 | 21.00 |
Land | - | - | 4.17 | - | - |
Buildings | - | 90.9 | 45.49 | - | - |
Machinery | - | 54.43 | 53.43 | - | - |
Construction In Progress | - | - | 37.78 | - | - |